Shelved drug given second chance to combat cancer
16th Jan 2006, 05:42 GMT
DURHAM - Adherex Technologies wants to offer the medical world something akin to a bodyguard for the cancer fighting drug commonly called 5-FU.
Shelved drug given second chance to combat cancer related news:
- Man pleads for Herceptin — The Cancer Blog
- Drug Approved to Prevent Breast Cancer Recurrence (HealthDay) — Yahoo! Health: Breast Cancer News
- Genes affect benefits of breast cancer drug — KeralaNext: Health
- Woman's £30,000 cancer drug bill — BBC News | Latest Published Stories | UK Edition
- Cancer drug woman wins mums award — BBC News | England | Somerset | UK Edition
- Genes affect benefits of breast cancer drug (Reuters) — Yahoo! News: Health News
- Cancer drug sales lift Genentech quarterly profit (Reuters) — Yahoo! News: Earnings News
- Cancer drug sales lift Genentech quarterly profit — washingtonpost.com -
- A Family's Mission to Combat Lung Cancer — ABC News: GMA
- Cancer Drugs Lift Earnings at Genentech — NYT > Business
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- United BioSource makes 10th buy, looks for more
- Nonprofits starting to invest in drug companies
- Accentia making changes to its business formula, market focus
- GSK terminates agreement for Genaera frog product
- Gladstone and Merck team to bring drugs to market
- Abbott expects to double vascular business sales
- Mayo to shut down drug-testing unit
- MIT, Dana-Farber win major cancer grants
- Service Bancorp chair resigns
- Introgen strikes nanotech deal with M.D. Anderson